Acorah Software Products - Accounts Production 16.0.110 true true 31 October 2023 1 November 2022 false true No description of principal activity 1 November 2023 31 October 2024 31 October 2024 12934824 Mr Mostafa Hassanein iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12934824 2023-10-31 12934824 2024-10-31 12934824 2023-11-01 2024-10-31 12934824 frs-core:CurrentFinancialInstruments 2024-10-31 12934824 frs-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 12934824 frs-bus:FilletedAccounts 2023-11-01 2024-10-31 12934824 frs-bus:Micro-entities 2023-11-01 2024-10-31 12934824 frs-bus:EntityHasNeverTraded 2023-11-01 2024-10-31 12934824 frs-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 12934824 frs-bus:Director1 2023-11-01 2024-10-31 12934824 2022-10-31 12934824 2023-10-31 12934824 2022-11-01 2023-10-31 12934824 frs-core:CurrentFinancialInstruments 2023-10-31
Registered number: 12934824
Majestic Biopharma (UK) Limited
Financial Statements
For The Year Ended 31 October 2024
BS ACCOUNTING SERVICES
Balance Sheet
Registered number: 12934824
2024 2023
£ £
Current assets 8,468 10,455
Creditors: Amounts Falling Due Within One Year (16,724 ) (18,584 )
NET CURRENT LIABILITIES (8,256 ) (8,129 )
TOTAL ASSETS LESS CURRENT LIABILITIES (8,256 ) (8,129 )
Accruals and deferred income (250 ) (250 )
NET LIABILITIES (8,506 ) (8,379 )
CAPITAL AND RESERVES (8,506 ) (8,379 )

Notes

1. General Information
Majestic Biopharma (UK) Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12934824 . The registered office is 128 City Road, London, EC1V 2NX.
2. Average Number of Employees
Average number of employees, including directors, during the year was: (2023: )
- -
3. Directors Advances, Credits and Guarantees
The above loan is unsecured, interest free and repayable on demand.
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Mostafa Hassanein
Director
25th November 2024